Cancer Advances, Inc.
Get Full AccessDescription
- Cancer Advances is a biotechnology company focused on impacting human health and the progression of gastrointestinal cancer by enhancing the adaptive immune system. The company's lead compound, Polyclonal Antibody Stimulator (PAS), is an immunomodulator used to treat gastrointestinal cancer.
-
Headquarters: , Durham, North Carolina, United States
More -
Phone Number:
-
Website: https://www.canceradvancesinc.com
-
Employees:2
-
Revenue:$1 - 10M
-
Legal Name:Cancer Advances, Inc.
-
Cancer Advances, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Cancer Advances, Inc.
-
What is Cancer Advances, Inc.'s official website?
Cancer Advances, Inc.'s official website is https://www.canceradvancesinc.com
-
What is Cancer Advances, Inc.'s Revenue?
Cancer Advances, Inc.'s revenue is $1 - 10M
-
What is Cancer Advances, Inc.'s NAICS code?
Cancer Advances, Inc.'s NAICS code is 541713
-
How many employees are working in Cancer Advances, Inc.
Cancer Advances, Inc. has 2 employees
-
What is Cancer Advances, Inc.'s Industry?
Cancer Advances, Inc. is in the industry of Biotechnology
-
Who is Cancer Advances, Inc.'s Director?
Cancer Advances, Inc.'s Director is Teresa Phillips